US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 1.200
  • +0.030+2.56%
Close Jul 22 16:00 ET
  • 1.200
  • 0.0000.00%
Post 17:16 ET
45.04MMarket Cap-231P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
182.52%582K
268.00%1.38M
57.98%376K
148.91%341K
457K
206K
375K
238K
137K
0
Operating revenue
182.52%582K
268.00%1.38M
57.98%376K
148.91%341K
--457K
--206K
--375K
--238K
--137K
--0
Cost of revenue
788.89%80K
6,200.00%1.26M
7,833.33%714K
4,554.55%512K
26K
9K
20K
9K
11K
0
Gross profit
154.82%502K
-66.20%120K
-247.60%-338K
-235.71%-171K
431K
197K
355K
229K
126K
0
Operating expense
-52.01%24.67M
4.84%167.74M
-63.22%19.54M
12.39%43.96M
45.63%52.85M
63.26%51.4M
49.62%160M
103.29%53.12M
45.89%39.12M
31.42%36.29M
Selling and administrative expenses
-43.78%13.26M
21.31%83.41M
-53.53%9.6M
42.75%24.34M
40.75%25.87M
82.61%23.6M
26.80%68.76M
51.86%20.66M
14.62%17.05M
30.33%18.38M
-Selling and marketing expense
----
-4.01%12.49M
-92.15%319K
9.17%2.99M
1.89%4.81M
----
--13.01M
--4.07M
--2.74M
33.80%4.72M
-General and administrative expense
-43.78%13.26M
27.21%70.93M
-44.07%9.28M
49.17%21.36M
54.17%21.06M
82.61%23.6M
2.82%55.76M
21.98%16.6M
-3.78%14.32M
29.18%13.66M
Research and development costs
-58.99%11.4M
-7.58%84.33M
-69.40%9.93M
-11.07%19.62M
50.64%26.97M
49.79%27.8M
73.10%91.24M
159.15%32.46M
84.88%22.06M
32.55%17.91M
Operating profit
52.80%-24.16M
-4.99%-167.62M
62.42%-19.88M
-13.19%-44.13M
-44.44%-52.41M
-62.64%-51.2M
-49.29%-159.65M
-102.41%-52.89M
-45.42%-38.99M
-31.42%-36.29M
Net non-operating interest income expense
-96.75%-2.66M
-34.83%-7.67M
-73.57%-2.49M
24.09%-2.18M
-18.52%-1.64M
-17,000.00%-1.35M
-142,225.00%-5.69M
-24,000.00%-1.43M
-287,800.00%-2.88M
-22,933.33%-1.38M
Non-operating interest income
-53.00%947K
123.46%5.65M
-36.34%946K
29.77%1.07M
694.61%1.62M
13,333.33%2.02M
5,645.45%2.53M
--1.49M
--823K
1,940.00%204K
Non-operating interest expense
7.13%3.61M
62.11%13.31M
17.64%3.44M
-12.11%3.25M
105.49%3.26M
48,000.00%3.37M
20,432.50%8.21M
--2.92M
--3.7M
9,812.50%1.59M
Other net income (expense)
113.01%32K
-782.67%-3.77M
122.50%108K
-6,822.58%-4.17M
537K
-246K
-427K
-480K
62K
Special income (charges)
----
---4.16M
--0
---4.16M
----
----
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
----
--4.16M
--0
--4.16M
----
----
--0
--0
--0
----
Other non- operating income (expenses)
113.01%32K
192.27%394K
122.50%108K
-108.06%-5K
--537K
---246K
---427K
---480K
--62K
----
Income before tax
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.78%-54.81M
-55.92%-41.81M
-36.39%-37.67M
Income tax
Net income
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.78%-54.81M
-55.92%-41.81M
-36.39%-37.67M
Net income continuous Operations
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.78%-54.81M
-55.92%-41.81M
-36.39%-37.67M
Minority interest income
Net income attributable to the parent company
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.79%-54.81M
-55.92%-41.81M
-36.39%-37.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.79%-54.81M
-55.92%-41.81M
-36.39%-37.67M
Basic earnings per share
52.72%-0.87
-3.89%-6.15
61.03%-0.76
-15.44%-1.72
-35.56%-1.83
-64.29%-1.84
-46.17%-5.92
-109.68%-1.95
-55.21%-1.49
-21.62%-1.35
Diluted earnings per share
52.72%-0.87
-3.89%-6.15
61.03%-0.76
-15.44%-1.72
-35.56%-1.83
-64.29%-1.84
-46.17%-5.92
-109.68%-1.95
-55.21%-1.49
-21.62%-1.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 182.52%582K268.00%1.38M57.98%376K148.91%341K457K206K375K238K137K0
Operating revenue 182.52%582K268.00%1.38M57.98%376K148.91%341K--457K--206K--375K--238K--137K--0
Cost of revenue 788.89%80K6,200.00%1.26M7,833.33%714K4,554.55%512K26K9K20K9K11K0
Gross profit 154.82%502K-66.20%120K-247.60%-338K-235.71%-171K431K197K355K229K126K0
Operating expense -52.01%24.67M4.84%167.74M-63.22%19.54M12.39%43.96M45.63%52.85M63.26%51.4M49.62%160M103.29%53.12M45.89%39.12M31.42%36.29M
Selling and administrative expenses -43.78%13.26M21.31%83.41M-53.53%9.6M42.75%24.34M40.75%25.87M82.61%23.6M26.80%68.76M51.86%20.66M14.62%17.05M30.33%18.38M
-Selling and marketing expense -----4.01%12.49M-92.15%319K9.17%2.99M1.89%4.81M------13.01M--4.07M--2.74M33.80%4.72M
-General and administrative expense -43.78%13.26M27.21%70.93M-44.07%9.28M49.17%21.36M54.17%21.06M82.61%23.6M2.82%55.76M21.98%16.6M-3.78%14.32M29.18%13.66M
Research and development costs -58.99%11.4M-7.58%84.33M-69.40%9.93M-11.07%19.62M50.64%26.97M49.79%27.8M73.10%91.24M159.15%32.46M84.88%22.06M32.55%17.91M
Operating profit 52.80%-24.16M-4.99%-167.62M62.42%-19.88M-13.19%-44.13M-44.44%-52.41M-62.64%-51.2M-49.29%-159.65M-102.41%-52.89M-45.42%-38.99M-31.42%-36.29M
Net non-operating interest income expense -96.75%-2.66M-34.83%-7.67M-73.57%-2.49M24.09%-2.18M-18.52%-1.64M-17,000.00%-1.35M-142,225.00%-5.69M-24,000.00%-1.43M-287,800.00%-2.88M-22,933.33%-1.38M
Non-operating interest income -53.00%947K123.46%5.65M-36.34%946K29.77%1.07M694.61%1.62M13,333.33%2.02M5,645.45%2.53M--1.49M--823K1,940.00%204K
Non-operating interest expense 7.13%3.61M62.11%13.31M17.64%3.44M-12.11%3.25M105.49%3.26M48,000.00%3.37M20,432.50%8.21M--2.92M--3.7M9,812.50%1.59M
Other net income (expense) 113.01%32K-782.67%-3.77M122.50%108K-6,822.58%-4.17M537K-246K-427K-480K62K
Special income (charges) -------4.16M--0---4.16M----------0--0--0----
-Less：Restructuring and merger&acquisition ------4.16M--0--4.16M----------0--0--0----
Other non- operating income (expenses) 113.01%32K192.27%394K122.50%108K-108.06%-5K--537K---246K---427K---480K--62K----
Income before tax 49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.78%-54.81M-55.92%-41.81M-36.39%-37.67M
Income tax
Net income 49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.78%-54.81M-55.92%-41.81M-36.39%-37.67M
Net income continuous Operations 49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.78%-54.81M-55.92%-41.81M-36.39%-37.67M
Minority interest income
Net income attributable to the parent company 49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.79%-54.81M-55.92%-41.81M-36.39%-37.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.79%-54.81M-55.92%-41.81M-36.39%-37.67M
Basic earnings per share 52.72%-0.87-3.89%-6.1561.03%-0.76-15.44%-1.72-35.56%-1.83-64.29%-1.84-46.17%-5.92-109.68%-1.95-55.21%-1.49-21.62%-1.35
Diluted earnings per share 52.72%-0.87-3.89%-6.1561.03%-0.76-15.44%-1.72-35.56%-1.83-64.29%-1.84-46.17%-5.92-109.68%-1.95-55.21%-1.49-21.62%-1.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg